Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo


Unsupported browser: Your browser does not meet modern web standards. See how it scores »

{ action.text }

Over the last few years, a small slice of medicine has moved out of the doctor’s office and into clinics at CVS, Walmart, or other retail outlets. QuickCheck Health, a startup based in Excelsior, Minnesota, aims to push this trend further by bringing more diagnostic testing to the home. The company is developing tests for urinary tract infections, strep throat, and other ailments that will be sold at drugstores for consumers to use at home.

While consumer diagnostic tests are already in use for pregnancy, ovulation, fertility, HIV, and other conditions, treatment or follow-up care requires a visit to the doctor. At-home tests for other conditions, such as urinary tract infections, are available, but most doctors are reluctant to prescribe antibiotics or other medication without validating the results.

QuickCheck Health plans to change that by requiring patients to log on to a website or call to learn the results of the test. If the test is positive, the user will be directed to an online health-care provider, who can prescribe treatment.

“The consumer doesn’t know what they have until they check in online or via phone, and the remote provider has confidence that this was a positive test,” says QuickCheck CEO Tom Henke. “That confirmation makes us different, and valuable to consumers and physicians.”

The tests employ existing chemical assays to detect infections or other issues using urine samples or a throat swab. The company has developed proprietary hardware to encode the results, as well as software for the website and database that patients and physicians will access. It plans to partner with networks of health-care providers across the country that would check the results via QuickCheck’s interface and provide prescriptions.

The company has developed a prototype of its urinary tract infection test and is planning trials to get consumer feedback on the design. It aims to get approval from the U.S. Food and Drug Administration later this year.

2 comments. Share your thoughts »

Credit: QuickCheck Health

Tagged: Biomedicine, diagnostics, healthcare, urinary tract infection

Reprints and Permissions | Send feedback to the editor

From the Archives


Introducing MIT Technology Review Insider.

Already a Magazine subscriber?

You're automatically an Insider. It's easy to activate or upgrade your account.

Activate Your Account

Become an Insider

It's the new way to subscribe. Get even more of the tech news, research, and discoveries you crave.

Sign Up

Learn More

Find out why MIT Technology Review Insider is for you and explore your options.

Show Me